Replagal (agalsidase alfa)
HGT-REP-084
Phase 2 mab completed
Quick answer
Replagal (agalsidase alfa) for Fabry Disease is a Phase 2 program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Fabry Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- completed